You are here
Dr Ghazaleh Dashti
Dr S Ghazaleh Dashti is a postdoctoral research fellow within the Clinical Epidemiology and Biostatistics Unit at MCRI. Her research focuses on the application of causal inference methods in observational studies and methods for handling missing data in the context of causal inference. She also provides statistical support for The Centre for Adolescent Health.
She was awarded a PhD in Epidemiology from The University of Melbourne in July 2020, a Master of Public Health from The University of Melbourne in 2015, and a Doctor of Dental Surgery from Shahid Beheshti University in Iran in 2011.
Prior to joining MCRI, Dr Dashti worked as an epidemiologist at the Colorectal Cancer Unit (2014-2017), and the Australian National Development Index Project (2018) at the University of Melbourne. She has also held various teaching roles and has been involved in student supervision since 2014.
Methodology projects in the areas above
Collaborative projects in adolescent health and cancer epidemiology
Dashti SG, English DR, Simpson JA, Karahalios A, Moreno-Betancur M, Biessy C, et al. Adiposity and endometrial cancer risk in postmenopausal women: a sequential causal mediation analysis. Cancer Epidemiol Biomarkers Prev. 2020.
Dashti SG, Viallon V, Simpson JA, Karahalios A, Moreno-Betancur M, English DR, et al. Explaining the link between adiposity and colorectal cancer risk in men and postmenopausal women in the UK Biobank: A sequential causal mediation analysis. Int J Cancer. 2020.
Dashti SG, Simpson JA, Karahalios A, Viallon V, Moreno-Betancur M, Gurrin LC, et al. Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol. Int J Cancer. 2020;146(6):1541-52.
Dempsey P, Matthews C, Dashti SG, Doherty A, Bergouignan A, van Roekel E, Dunstan D et al. Sedentary Behaviour and Chronic Disease: Mechanisms and Future Directions. J Phys Act Health 2019 accepted 2019/10/04; doi.org/10.17863/CAM.44855.
Dashti SG, Li WY, Buchanan DD, Clendenning M, Rosty C, Winship IM et al. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer 2019; e-pub ahead of print 2019/09/26; doi 10.1038/s41416-019-0580-9.
Assi N, Rinaldi S, Viallon V, Dashti SG, Dossus L, Fournier A et al. Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort. Int J Cancer 2019; e-pub ahead of print 2019/04/11; doi 10.1002/ijc.32324.
Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S et al. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 2018; 143(9): 2250-2260; e-pub ahead of print 2018/06/16; doi 10.1002/ijc.31611.
Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C et al. Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers. Cancer Epidemiol Biomarkers Prev 2017; 26(3): 366-375; e-pub ahead of print 2016/11/05; doi 10.1158/1055-9965.EPI-16-0496.
Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D et al. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study. Int J Cancer (Clinical report) 2016; 139(5): 1081-1090; e-pub ahead of print 2016/04/22; doi 10.1002/ijc.30153.
Dashti SG, Chau R, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C et al. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol 2016; 45(3): 940-953; e-pub ahead of print 2016/04/12; doi 10.1093/ije/dyw036.
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP et al. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome. Jama-J Am Med Assoc (Report) 2015; 314(1): 61-71; e-pub ahead of print 2015/07/08; doi 10.1001/jama.2015.6789.
Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C et al. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst 2015; 107(9): 1-11; e-pub ahead of print 2015/06/26; doi 10.1093/jnci/djv170.